Effects of SGLT-2 inhibitors and GLP-1 receptor agonists on liver function in patients with non-alcoholic fatty liver disease and type 2 diabetes - Quiz - MDSpire

Effects of SGLT-2 inhibitors and GLP-1 receptor agonists on liver function in patients with non-alcoholic fatty liver disease and type 2 diabetes

  • By

  • Wancheng Guo

  • Wenhe Li

  • Xianlin Li

  • Wen Shi

  • Yan Yan

  • Ting Yan

  • Jie Zhou

  • Yujie Huang

  • June 3, 2026

  • 0 min

Share

Original Source(s)

Effects of SGLT-2 inhibitors and GLP-1 receptor agonists on liver function in patients with non-alcoholic fatty liver disease and type 2 diabetes

  • by Wancheng Guo, Wenhe Li, Xianlin Li, Wen Shi, Yan Yan, Ting Yan, Jie Zhou, Yujie Huang

  • June 3, 2026

Related Content

East is East

Is ophthalmology in the East really that much different to the West?

Lipoprotein (a) and incident coronary heart disease in the community: impact of traditional cardiovascular risk factors

New dietary guidelines urge Americans to avoid processed foods